|
US6777217B1
(en)
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
|
US20030129724A1
(en)
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
|
CA2492035A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Vicuron Pharmaceuticals, Inc. |
N-hydroxyamide derivatives possessing antibacterial activity
|
|
ES2387803T3
(es)
|
2003-01-08 |
2012-10-02 |
Novartis Vaccines And Diagnostics, Inc. |
Agentes antibacterianos
|
|
EP2256106B1
(en)
|
2003-07-22 |
2015-05-06 |
Astex Therapeutics Limited |
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
|
|
WO2005046683A1
(en)
|
2003-10-07 |
2005-05-26 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
KR20060123344A
(ko)
*
|
2003-12-19 |
2006-12-01 |
바스프 악티엔게젤샤프트 |
벤조일-치환된 페닐알라닌아미드
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US7638513B2
(en)
|
2004-06-02 |
2009-12-29 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
WO2006022442A1
(ja)
*
|
2004-08-24 |
2006-03-02 |
Santen Pharmaceutical Co., Ltd. |
ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体
|
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
PL383715A1
(pl)
|
2005-01-26 |
2008-05-12 |
Allergan, Inc. |
Amidy kwasu 3-arylo-3-hydroksy-2-amino-propionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-amino-propionowego i ich związki pokrewne posiadające aktywność przeciwbólową i/lub pobudzającą odporność
|
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
|
US20080300243A1
(en)
*
|
2005-02-28 |
2008-12-04 |
Kelly Michael G |
Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
|
|
SG171690A1
(en)
|
2005-03-22 |
2011-06-29 |
Harvard College |
Treatment of protein degradation disorders
|
|
MY144590A
(en)
*
|
2005-07-11 |
2011-10-14 |
Wyeth Corp |
Glutamate aggrecanase inhibitors
|
|
JP4961773B2
(ja)
*
|
2005-07-29 |
2012-06-27 |
住友ベークライト株式会社 |
芳香族カルボン酸及びその酸ハロゲン化物
|
|
JP2009520695A
(ja)
*
|
2005-12-15 |
2009-05-28 |
ヴィキュロン ファーマシューティカルズ インコーポレイテッド |
抗菌活性を有するｎ−ヒドロキシアミド誘導体
|
|
WO2008091349A1
(en)
*
|
2006-02-14 |
2008-07-31 |
The President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
|
WO2007130429A2
(en)
|
2006-05-03 |
2007-11-15 |
The President And Fellows Of Harvard College |
Histone deacetylase and tubulin deacetylase inhibitors
|
|
MX2008015226A
(es)
|
2006-05-30 |
2008-12-12 |
Astrazeneca Ab |
Derivados de 1,3,4-oxadiazol como inhibidores de dgat1.
|
|
DE102006033321A1
(de)
*
|
2006-07-17 |
2008-01-24 |
Westfälische Wilhelms-Universität Münster |
Medizinische Verwendung von N-Phenylpropenoyl-Aminosäurederivaten und verwandten Verbindungen
|
|
JP2009544611A
(ja)
|
2006-07-20 |
2009-12-17 |
メルク エンド カムパニー インコーポレーテッド |
ヒストン脱アセチル化酵素阻害剤としてのリン誘導体
|
|
AU2007276763B2
(en)
*
|
2006-07-24 |
2011-03-17 |
University Of Maryland, Baltimore |
Heme oxygenase inhibitors and methods of therapeutic use
|
|
TW200821276A
(en)
*
|
2006-08-18 |
2008-05-16 |
Leo Pharma As |
Substituted acetylenic compounds useful for the treatment of diseases
|
|
CN101528711A
(zh)
|
2006-08-31 |
2009-09-09 |
先灵公司 |
可用作抗细菌剂的乙内酰脲衍生物
|
|
CA2680507A1
(en)
*
|
2006-10-13 |
2008-04-24 |
Xtl Biopharmaceuticals Ltd. |
Compounds and methods for treatment of hcv
|
|
CA2668070A1
(en)
|
2006-10-30 |
2008-05-08 |
Chroma Therapeutics Ltd. |
Hydroxamates as inhibitors of histone deacetylase
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
WO2008105515A1
(ja)
*
|
2007-02-28 |
2008-09-04 |
Taisho Pharmaceutical Co., Ltd. |
新規なヒドロキサム酸誘導体
|
|
US8093265B2
(en)
|
2007-03-09 |
2012-01-10 |
Renovis, Inc. |
Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
|
|
CA2691987C
(en)
*
|
2007-06-12 |
2016-08-16 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN101417937B
(zh)
*
|
2007-10-23 |
2013-05-29 |
中山大学 |
β-醛酮类抗菌化合物及其应用
|
|
EP2234608A2
(en)
|
2007-12-11 |
2010-10-06 |
Viamet Pharmaceuticals, Inc. |
Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
|
|
AR069802A1
(es)
|
2007-12-20 |
2010-02-17 |
Astrazeneca Ab |
Compuestos de carbamoilo como inhibidores de dgat1 190
|
|
US20110212078A1
(en)
|
2008-06-25 |
2011-09-01 |
Reddy Panduranga Adulla P |
Synthesis and use of heterocyclic antibacterial agents
|
|
EP2321264B1
(en)
|
2008-07-23 |
2016-05-04 |
President and Fellows of Harvard College |
Deacetylase inhibitors and uses thereof
|
|
US8580859B2
(en)
|
2008-08-01 |
2013-11-12 |
Bioxiness Pharmaceuticals, Inc. |
Methionine analogs and methods of using same
|
|
WO2010017060A1
(en)
*
|
2008-08-04 |
2010-02-11 |
Schering Corporation |
Urea derivatives as antibacterial agents
|
|
US8273900B2
(en)
|
2008-08-07 |
2012-09-25 |
Novartis Ag |
Organic compounds
|
|
US8372885B2
(en)
*
|
2008-09-17 |
2013-02-12 |
Novartis Ag |
Organic compounds and their uses
|
|
US8722686B2
(en)
|
2008-09-19 |
2014-05-13 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
|
EP2177502A1
(en)
*
|
2008-10-17 |
2010-04-21 |
Oryzon Genomics, S.A. |
Compounds and their use
|
|
WO2010043721A1
(en)
|
2008-10-17 |
2010-04-22 |
Oryzon Genomics, S.A. |
Oxidase inhibitors and their use
|
|
US8993808B2
(en)
|
2009-01-21 |
2015-03-31 |
Oryzon Genomics, S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
|
KR20120023663A
(ko)
*
|
2009-05-25 |
2012-03-13 |
키에시 파르마슈티시 엣스. 피. 에이. |
폐 계면활성제 및 스테로이드를 포함하는 치료적 조합
|
|
MX2011014018A
(es)
|
2009-06-19 |
2012-02-22 |
Astrazeneca Ab |
Pirazincarboxamidas como inhibidores de dgati.
|
|
US8716344B2
(en)
|
2009-08-11 |
2014-05-06 |
President And Fellows Of Harvard College |
Class- and isoform-specific HDAC inhibitors and uses thereof
|
|
FR2950056B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2950057B1
(fr)
|
2009-09-17 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-carboxylamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
WO2011035941A1
(en)
|
2009-09-25 |
2011-03-31 |
Oryzon Genomics S.A. |
Lysine specific demethylase-1 inhibitors and their use
|
|
US8946296B2
(en)
|
2009-10-09 |
2015-02-03 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
|
|
JP5793766B2
(ja)
|
2009-12-16 |
2015-10-14 |
ファイザー・インク |
抗菌剤として有用なｎ−結合型ヒドロキサム酸誘導体
|
|
WO2011106574A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Inhibitors for antiviral use
|
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
RS55348B1
(sr)
|
2010-04-19 |
2017-03-31 |
Oryzon Gnomics S A |
Inhibitori lizin specifične demetilaze-1 i njihova upotreba
|
|
RS59255B1
(sr)
|
2010-04-20 |
2019-10-31 |
Fujifilm Toyama Chemical Co Ltd |
Derivat hidroksaminske kiseline
|
|
RU2569678C2
(ru)
|
2010-04-22 |
2015-11-27 |
Вертекс Фармасьютикалз Инкорпорейтед |
Способ получения циклоалкилкарбоксамидо-индольных соединений
|
|
EP2598480B1
(en)
|
2010-07-29 |
2019-04-24 |
Oryzon Genomics, S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
|
DK2598482T3
(en)
|
2010-07-29 |
2018-06-14 |
Oryzon Genomics Sa |
ARYLCYCLOPROPYLAMINE-BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE
|
|
US9738604B2
(en)
|
2010-09-03 |
2017-08-22 |
Duke University |
Ethynylbenzene derivatives
|
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
|
EP2638006A1
(en)
|
2010-11-10 |
2013-09-18 |
Achaogen, Inc. |
Hydroxamic acid derivatives and their use in the treatment of bacterial infections
|
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
|
CN103402996B
(zh)
|
2011-01-04 |
2015-02-11 |
诺瓦提斯公司 |
可用于治疗年龄相关性黄斑变性(amd)的吲哚化合物或其类似物
|
|
EP2712315B1
(en)
|
2011-02-08 |
2021-11-24 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
|
US8877940B2
(en)
|
2011-02-22 |
2014-11-04 |
Institut National De La Recherche Scientifique |
Antibiotic tolerance inhibitors
|
|
AP3336A
(en)
|
2011-03-07 |
2015-07-31 |
Pfizer |
Fluoro-pyridinone derivatives useful as antibacterial agents
|
|
WO2012137099A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
|
|
WO2012137094A1
(en)
|
2011-04-08 |
2012-10-11 |
Pfizer Inc. |
Isoxazole derivatives useful as antibacterial agents
|
|
US20150203444A1
(en)
|
2011-09-12 |
2015-07-23 |
Achaogen, Inc. |
Polymorphs of n-((s)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1r,2r)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
JP6006609B2
(ja)
*
|
2011-10-19 |
2016-10-12 |
大正製薬株式会社 |
新規なヒドロキサム酸誘導体を含有する医薬
|
|
US9469597B2
(en)
|
2011-10-20 |
2016-10-18 |
Oryzon Genomics S.A. |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
|
AU2012324803B9
(en)
|
2011-10-20 |
2017-08-24 |
Oryzon Genomics, S.A. |
(hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
|
KR20140132367A
(ko)
*
|
2012-02-16 |
2014-11-17 |
알큐엑스 파마슈티컬스, 인크. |
선형 펩티드 항생제
|
|
WO2013170165A1
(en)
|
2012-05-10 |
2013-11-14 |
Achaogen, Inc. |
Antibacterial agents
|
|
CN104619698B
(zh)
|
2012-06-28 |
2016-08-31 |
诺华股份有限公司 |
吡咯烷衍生物及其作为补体途径调节剂的用途
|
|
CN104640855B
(zh)
|
2012-06-28 |
2017-08-29 |
诺华股份有限公司 |
补体途经调节剂及其用途
|
|
WO2014002051A2
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
EP2867229B1
(en)
|
2012-06-28 |
2017-07-26 |
Novartis AG |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
JP6209605B2
(ja)
|
2012-06-28 |
2017-10-04 |
ノバルティス アーゲー |
ピロリジン誘導体、および補体経路調節因子としてのその使用
|
|
US9550755B2
(en)
|
2012-07-12 |
2017-01-24 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
CN103012207B
(zh)
*
|
2012-12-29 |
2015-05-27 |
吉首大学 |
二芳基丙酰-n-甲基氧肟酸类尿素酶抑制剂及其合成和用途
|
|
WO2014165075A1
(en)
*
|
2013-03-12 |
2014-10-09 |
Achaogen, Inc. |
Antibacterial agents
|
|
EP2975022B1
(en)
|
2013-03-15 |
2019-05-08 |
FUJIFILM Toyama Chemical Co., Ltd. |
Novel hydroxamic acid derivative or salt thereof
|
|
WO2014160649A1
(en)
*
|
2013-03-29 |
2014-10-02 |
Novartis Ag |
Hydroxamic acid derivatives as lpxc inhibitors for the treatment of bacterial infections
|
|
AU2014306451B2
(en)
*
|
2013-08-16 |
2019-01-17 |
Duke University |
Substituted hydroxamic acid compounds
|
|
WO2015024016A2
(en)
|
2013-08-16 |
2015-02-19 |
Duke University |
2-piperidinyl substituted n,3-dihydroxybutanamides
|
|
WO2015024011A2
(en)
*
|
2013-08-16 |
2015-02-19 |
Duke University |
Antibacterial compounds
|
|
GB201315335D0
(en)
|
2013-08-29 |
2013-10-09 |
Of Singapore |
Amino diacids containing peptide modifiers
|
|
US9539305B1
(en)
|
2014-03-14 |
2017-01-10 |
Fleurir Abx Llc |
Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
|
|
PL3925607T5
(pl)
|
2014-04-15 |
2026-06-01 |
Vertex Pharmaceuticals Incorporated |
Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
|
|
CN106573924B
(zh)
|
2014-04-22 |
2019-06-25 |
诺华股份有限公司 |
作为LpxC抑制剂的异噁唑啉异羟肟酸衍生物
|
|
CN106794162A
(zh)
|
2014-09-12 |
2017-05-31 |
富山化学工业株式会社 |
组合使用新的异羟肟酸衍生物和抗菌性物质的方法
|
|
CA2960949A1
(en)
|
2014-09-12 |
2016-03-17 |
Tatsuya Honda |
Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
|
|
CN104327140B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁唑烷酮-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104262433B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-腺苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341475A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-腺苷型多靶点抗菌化合物及其制法和用途
|
|
CN104231024B
(zh)
*
|
2014-10-11 |
2016-06-15 |
吉首大学 |
噁二唑-肌苷型化合物作为TyrRS抑制剂及其制法和用途
|
|
CN104341476A
(zh)
*
|
2014-10-11 |
2015-02-11 |
吉首大学 |
利奈唑胺-肌苷型多靶点抗菌化合物及其制法和用途
|
|
HUE047225T2
(hu)
|
2014-12-16 |
2020-04-28 |
Novartis Ag |
LpxC inhibitor izoxazol hidroxámsav-vegyületek
|
|
CN105777464B
(zh)
*
|
2014-12-26 |
2020-09-29 |
中国科学院上海药物研究所 |
异羟肟酸衍生物及其制备方法和应用
|
|
CN107709314A
(zh)
|
2015-06-11 |
2018-02-16 |
巴斯利尔药物国际股份公司 |
外排泵抑制剂及其治疗性用途
|
|
WO2017042099A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Basilea Pharmaceutica Ag |
Efflux-pump inhibitors and therapeutic uses thereof
|
|
EP3374350B1
(en)
|
2015-11-09 |
2022-01-05 |
Forge Therapeutics, Inc. |
Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
|
|
US10611747B2
(en)
|
2015-11-09 |
2020-04-07 |
Forge Therapeutics, Inc. |
Pyrone based compounds for treating bacterial infections
|
|
WO2017098440A1
(en)
*
|
2015-12-08 |
2017-06-15 |
Glaxosmithkline Intellectual Property Development Limited |
Substituted benzazinones as antibacterial compounds
|
|
WO2017156071A1
(en)
|
2016-03-09 |
2017-09-14 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
|
PL3445744T3
(pl)
|
2016-04-18 |
2022-02-07 |
Vivoryon Therapeutics Ag |
Nowe inhibitory mepryny alfa i beta
|
|
AU2017257755B2
(en)
*
|
2016-04-25 |
2021-05-06 |
Duke University |
Benzoylglycine derivatives and methods of making and using same
|
|
SMT202000524T1
(it)
|
2016-06-14 |
2020-11-10 |
Novartis Ag |
Forma cristallina di (r)-4-(5-(ciclopropiletinil)isossazol-3-il)-n-idrossi-2-metil-2-(metilsolfonil)butanammide come agente antibatterico
|
|
BR112018076766A2
(pt)
|
2016-06-21 |
2019-04-02 |
Orion Ophthalmology LLC |
derivados de prolinamida alifática
|
|
JP7179721B2
(ja)
|
2016-06-21 |
2022-11-29 |
オリオン・オフサルモロジー・エルエルシー |
複素環式プロリンアミド誘導体
|
|
JP7164521B2
(ja)
|
2016-06-21 |
2022-11-01 |
オリオン・オフサルモロジー・エルエルシー |
炭素環式プロリンアミド誘導体
|
|
WO2017223349A1
(en)
|
2016-06-23 |
2017-12-28 |
Achaogen, Inc. |
Antibacterial agents
|
|
AU2017292646A1
(en)
|
2016-07-05 |
2019-02-07 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
US10934261B2
(en)
|
2016-09-28 |
2021-03-02 |
Blade Therapeutics, Inc. |
Calpain modulators and therapeutic uses thereof
|
|
JP7082445B2
(ja)
|
2016-12-23 |
2022-06-08 |
インターベット インターナショナル ベー． フェー． |
ウシ又はブタの呼吸器疾患を治療するための化合物
|
|
US11034650B2
(en)
*
|
2016-12-23 |
2021-06-15 |
Intervet Inc. |
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
|
|
EP3621962A4
(en)
|
2017-05-10 |
2020-12-09 |
Forge Therapeutics, Inc. |
ANTIBACTERIAL COMPOUNDS
|
|
US11666555B2
(en)
|
2017-05-17 |
2023-06-06 |
Drexel University |
RelA inhibitors for biofilm disruption
|
|
AU2018300150A1
(en)
|
2017-07-11 |
2020-01-30 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
US11351126B2
(en)
|
2017-07-27 |
2022-06-07 |
BioMendics, LLC |
Substituted tolans for the modulation of microbial colonization
|
|
KR102868718B1
(ko)
*
|
2018-02-10 |
2025-10-14 |
케이비피 바이오사이언시즈 씨오., 엘티디. |
항생제로서 작용하는 화합물
|
|
WO2020061375A1
(en)
*
|
2018-09-20 |
2020-03-26 |
Forge Therapeutics, Inc. |
Antibacterial compounds
|
|
WO2020092394A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
|
|
DK3873884T3
(da)
|
2018-10-30 |
2025-02-17 |
Gilead Sciences Inc |
3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
|
|
WO2020092401A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
|
|
ES2987796T3
(es)
|
2018-10-30 |
2024-11-18 |
Gilead Sciences Inc |
Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
|
|
WO2020146682A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Carboxamides as modulators of sodium channels
|
|
WO2020146612A1
(en)
|
2019-01-10 |
2020-07-16 |
Vertex Pharmaceuticals Incorporated |
Esters and carbamates as modulators of sodium channels
|
|
AU2020224153B2
(en)
*
|
2019-02-22 |
2025-03-06 |
Cila Therapeutic Inc. |
Inhalable therapeutic agent
|
|
AU2020329207B2
(en)
|
2019-08-14 |
2024-02-29 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|
|
CN110563611B
(zh)
*
|
2019-09-19 |
2021-02-02 |
中国医学科学院医药生物技术研究所 |
一种异羟肟酸类衍生物及其制备方法和应用
|
|
PH12022551379A1
(en)
|
2019-12-06 |
2023-05-03 |
Vertex Pharma |
Substituted tetrahydrofurans as modulators of sodium channels
|
|
CN111254091B
(zh)
*
|
2020-01-20 |
2022-04-19 |
浙江工业大学 |
一种嗜麦芽窄食单胞菌gyh及其在降解氯代烃类污染物中的应用
|
|
WO2021195260A1
(en)
|
2020-03-25 |
2021-09-30 |
Forge Therapeutics, Inc. |
Lpxc inhibitor and methods of making
|
|
BR112022025037A2
(pt)
|
2020-06-10 |
2023-02-14 |
Aligos Therapeutics Inc |
Compostos antivirais para tratar infecções por coronavírus, picornavírus e norovírus
|
|
SI4347031T1
(sl)
|
2021-06-04 |
2026-01-30 |
Vertex Pharmaceuticals Incorporated |
N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov
|
|
WO2023283256A1
(en)
|
2021-07-09 |
2023-01-12 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
US12065428B2
(en)
|
2021-09-17 |
2024-08-20 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
AR127139A1
(es)
|
2021-09-28 |
2023-12-20 |
Forge Therapeutics Inc |
Inhibidores de lpxc y usos de estos
|
|
WO2023128033A1
(ko)
*
|
2021-12-31 |
2023-07-06 |
(주)앰틱스바이오 |
감염성 진균의 바이오필름 생성을 억제하는 신규한 항진균용 조성물
|
|
AU2023303408A1
(en)
|
2022-07-06 |
2024-12-19 |
Aligos Therapeutics, Inc. |
Anti-viral compounds
|
|
CN116730870B
(zh)
*
|
2023-08-08 |
2023-10-13 |
中国医学科学院医药生物技术研究所 |
异羟肟酸类化合物或其可药用盐、及其用途和制备方法
|
|
CN119350185B
(zh)
*
|
2024-10-08 |
2026-05-29 |
聊城大学 |
一种联苯羟肟类衍生物及其制备方法和用途
|
|
US20260174911A1
(en)
*
|
2024-12-20 |
2026-06-25 |
Novartis Ag |
Fap targeting compounds and conjugates thereof
|